Albert Newton

Abba Leffler Shares Insights on How AI and Physics-Based Modeling Are Shortening the Path from Idea to Drug Candidate

12.04.2025 21:50 PM

Advances in artificial intelligence and physics-driven computational methods have become crucial components of modern early-stage discovery. Abba Leffler's experience at the advanced computational discovery firm Schrödinger has demonstrated how these tools help shorten the path from an early idea to a real therapeutic opportunity.

Most Popular

Solar Flare Explosions: Understanding a Potential Sun Eruption, CMEs, and Space Weather Chaos

Osteoporosis Symptoms & Brittle Bones Warning: Why Women Over 40 Face Rapid Bone Density Loss

Microplastics Health Effects: Are Environmental Toxins and Plastic in the Bloodstream Dangerous?

Top 9 Natural Events and Atmospheric Phenomena That Are So Rare You May Never Witness Them

12 Early Disease Symptoms Most People Ignore That Could Be Serious Health Warning Signs